BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27718511)

  • 1. Oral probiotic treatment of Lactobacillus rhamnosus Lcr35
    Darbaky Y; Evrard B; Patrier S; Falenta J; Garcin S; Tridon A; Dapoigny M; Silberberg C; Nivoliez A; Diop L
    J Appl Microbiol; 2017 Jan; 122(1):188-200. PubMed ID: 27718511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®.
    Nivoliez A; Camares O; Paquet-Gachinat M; Bornes S; Forestier C; Veisseire P
    J Biotechnol; 2012 Aug; 160(3-4):236-41. PubMed ID: 22542933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches.
    Torres-Maravilla E; Carvalho FA; Holowacz S; Delannoy J; Lenoir L; Jacouton E; Barbut F; Langella P; Bermúdez-Humarán LG; Waligora-Dupriet AJ
    Benef Microbes; 2024 Apr; 15(3):293-310. PubMed ID: 38677716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
    Valibouze C; Dubuquoy C; Chavatte P; Genin M; Maquet V; Modica S; Desreumaux P; Rousseaux C
    World J Gastroenterol; 2024 Apr; 30(16):2258-2271. PubMed ID: 38690023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of manufacturing processes on cell surface properties of probiotic strain Lactobacillus rhamnosus Lcr35®.
    Nivoliez A; Veisseire P; Alaterre E; Dausset C; Baptiste F; Camarès O; Paquet-Gachinat M; Bonnet M; Forestier C; Bornes S
    Appl Microbiol Biotechnol; 2015 Jan; 99(1):399-411. PubMed ID: 25280746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats.
    Agostini S; Goubern M; Tondereau V; Salvador-Cartier C; Bezirard V; Lévèque M; Keränen H; Theodorou V; Bourdu-Naturel S; Goupil-Feuillerat N; Legrain-Raspaud S; Eutamene H
    Neurogastroenterol Motil; 2012 Apr; 24(4):376-e172. PubMed ID: 22272920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
    Dapoigny M; Piche T; Ducrotte P; Lunaud B; Cardot JM; Bernalier-Donadille A
    World J Gastroenterol; 2012 May; 18(17):2067-75. PubMed ID: 22563194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multispecies probiotic protects gut barrier function in experimental models.
    Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
    World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Tongxieyaofang decoction on colonic mucosal protein expression profiles in rats with visceral hypersensitivity.
    Lin Y; Ding Y; Lü B; Liu N
    J Tradit Chin Med; 2020 Apr; 40(2):245-252. PubMed ID: 32242390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium butyricum regulates visceral hypersensitivity of irritable bowel syndrome by inhibiting colonic mucous low grade inflammation through its action on NLRP6.
    Zhao K; Yu L; Wang X; He Y; Lu B
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):216-223. PubMed ID: 29329362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
    Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
    J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
    Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
    World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats.
    Ait-Belgnaoui A; Eutamene H; Houdeau E; Bueno L; Fioramonti J; Theodorou V
    Neurogastroenterol Motil; 2009 May; 21(5):567-73, e18-9. PubMed ID: 19309441
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhao Q; Yang WR; Wang XH; Li GQ; Xu LQ; Cui X; Liu Y; Zuo XL
    World J Gastroenterol; 2019 Sep; 25(36):5469-5482. PubMed ID: 31576093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
    Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
    Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons.
    King AJ; Chang L; Li Q; Liu L; Zhu Y; Pasricha PJ; Wang J; Siegel M; Caldwell JS; Edelstein S; Rosenbaum DP; Kozuka K
    Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G543-G554. PubMed ID: 38252683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model.
    Song YF; Pei LX; Chen L; Geng H; Yuan MQ; Xu WL; Wu J; Zhou JY; Sun JH
    Am J Chin Med; 2020; 48(1):77-90. PubMed ID: 31918565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
    Preston K; Krumian R; Hattner J; de Montigny D; Stewart M; Gaddam S
    Benef Microbes; 2018 Sep; 9(5):697-706. PubMed ID: 29888656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis.
    Liu YW; Wang YP; Yen HF; Liu PY; Tzeng WJ; Tsai CF; Lin HC; Lee FY; Jeng OJ; Lu CL; Tsai YC
    Probiotics Antimicrob Proteins; 2020 Sep; 12(3):980-993. PubMed ID: 31691208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.